The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A cell culture model for T lymphocyte clonal anergy
Schwartz, R. H. (1990) · Science · doi:10.1126/science.2113314 · Cited by 1,857
Mueller, D. L., Jenkins, M. K., & Schwartz, R. H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002305 · Cited by 1,493
Jenkins, M. K., & Schwartz, R. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.2.302 · Cited by 1,170
Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
Linsley, P. S., Clark, E. A., & Ledbetter, J. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5031 · Cited by 747
June, C. H., Ledbetter, J. A., Gillespie, M. M., Lindsten, T., & Thompson, C. B. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.12.4472 · Cited by 566
CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells
Jenkins, M. K., Taylor, P. S., Norton, S. D., & Urdahl, K. B. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2461 · Cited by 562
Gimmi, C. D., Freeman, G. J., Gribben, J. G., Sugita, K., Freedman, A. S., Morimoto, C., & Nadler, L. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6575 · Cited by 427
Freeman, G. J., Gray, G. S., Gimmi, C. D., Lombard, D. B., Zhou, L. J., White, M., Fingeroth, J. D., Gribben, J. G., & Nadler, L. M. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.625 · Cited by 344
Monoclonal antibodies identifying a novel T-Cell antigen and Ia antigens of human lymphocytes
Hansen, J. A., Martin, P. J., & Nowinski, R. C. (1980) · Immunogenetics · doi:10.1007/bf01561573 · Cited by 314
Cited by
Items 101–141 of 141
Prevention of T Cell Anergy by Signaling Through the γ c Chain of the IL-2 Receptor
Boussiotis, V. A., Barber, D. L., Nakarai, T., Freeman, G. J., Gribben, J. G., Bernstein, G. M., D'Andrea, A. D., Ritz, J., & Nadler, L. M. (1994) · Science · doi:10.1126/science.7973657 · Cited by 307
T cell anergy and costimulation
Appleman, L. J., & Boussiotis, V. A. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00009.x · Cited by 305
Los, M., Schenk, H., Hexel, K., Baeuerle, P. A., Dröge, W., & Schulze-Osthoff, K. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00043.x · Cited by 303
Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations.
Larsen, C. P., Ritchie, S. C., Pearson, T. C., Linsley, P. S., & Lowry, R. P. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.1215 · Cited by 302
Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
Fan, X., Quezada, S. A., Sepulveda, M. A., Sharma, P., & Allison, J. P. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130590 · Cited by 300
Self-citationPrasad, K. V., Cai, Y. C., Raab, M., Duckworth, B., Cantley, L., Shoelson, S. E., & Rudd, C. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2834 · Cited by 295
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.
Ho, W. Y., Cooke, M. P., Goodnow, C. C., & Davis, M. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1539 · Cited by 292
Immunomodulatory drug costimulates T cells via the B7-CD28 pathway
LeBlanc, R., Hideshima, T., Catley, L. P., Shringarpure, R., Burger, R., Mitsiades, N., Mitsiades, C., Cheema, P., Chauhan, D., Richardson, P. G., et al. (2004) · Blood · doi:10.1182/blood-2003-02-0361 · Cited by 289
Costimulatory and coinhibitory receptors in anti‐tumor immunity
Driessens, G., Kline, J., & Gajewski, T. F. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00771.x · Cited by 286
Anandasabapathy (2003) · doi:10.1016/s1074-7613(03)00084-0 · Cited by 285
The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo
Huang, L., Soldevila, G., Leeker, M., Flavell, R., & Crispe, I. N. (1994) · Immunity · doi:10.1016/s1074-7613(94)80016-2 · Cited by 283
ICOS is critical for T helper cell–mediated lung mucosal inflammatory responses
Gonzalo, J. A., Tian, J., Delaney, T., Corcoran, J., Rottman, J. B., Lora, J., Al-garawi, A., Kroczek, R., Gutierrez-Ramos, J. C., & Coyle, A. J. (2001) · Nature Immunology · doi:10.1038/89739 · Cited by 279
Augmentation of T cell levels and responses induced by androgen deprivation
Roden, A. C., Moser, M. T., Tri, S. D., Mercader, M., Kuntz, S. M., Dong, H., Hurwitz, A. A., McKean, D. J., Celis, E., Leibovich, B. C., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6098 · Cited by 276
Self-citationThe Nef protein of HIV-1 associates with rafts and primes T cells for activation
Wang, J.-K., Kiyokawa, E., Verdin, E., & Trono, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.394 · Cited by 276
Involvement of p21ras distinguishes positive and negative selection in thymocytes.
Swan, K. A., Alberola-Ila, J., Gross, J. A., Appleby, M. W., Forbush, K. A., Thomas, J. F., & Perlmutter, R. M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07001.x · Cited by 272
Self-citationLu, L., McCaslin, D., Starzl, T. E., & Thomson, A. W. (1995) · Transplantation · doi:10.1097/00007890-199560120-00028 · Cited by 271
Tewalt, E. F., Cohen, J. N., Rouhani, S. J., Guidi, C. J., Qiao, H., Fahl, S. P., Conaway, M. R., Bender, T. P., Tung, K. S., Vella, A. T., et al. (2012) · Blood · doi:10.1182/blood-2012-04-427013 · Cited by 270
Harding, F. A., & Allison, J. P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1791 · Cited by 265
Self-citationExpression and functional significance of an additional ligand for CTLA-4.
Lenschow, D. J., Su, G. H., Zuckerman, L. A., Nabavi, N., Jellis, C. L., Gray, G. S., Miller, J., & Bluestone, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11054 · Cited by 259
Pozzi, L.-A. M., Maciaszek, J. W., & Rock, K. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2071 · Cited by 259
Hwang, I., Huang, J.-F., Kishimoto, H., Brunmark, A., Peterson, P. A., Jackson, M. R., Surh, C. D., Cai, Z., & Sprent, J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1137 · Cited by 255
Releasing the Brakes on Cancer Immunotherapy
Ribas, A. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1510079 · Cited by 252
The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti–CTLA-4 Therapy
Fu, T., He, Q., & Sharma, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1138 · Cited by 243
Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms
Moslehi, J., Lichtman, A. H., Sharpe, A. H., Galluzzi, L., & Kitsis, R. N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145186 · Cited by 237
E3 ubiquitin ligases as T cell anergy factors
Mueller, D. L. (2004) · Nature Immunology · doi:10.1038/ni1106 · Cited by 224
Wells, A. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803917 · Cited by 153
CD28: a signalling perspective
WARD, S. G. (1996) · Biochemical Journal · doi:10.1042/bj3180361 · Cited by 149
Li, L.-B., Goleva, E., Hall, C. F., Ou, L.-S., & Leung, D. Y. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.005 · Cited by 127
Wei, S. C., Sharma, R., Anang, N.-A. A. S., Levine, J. H., Zhao, Y., Mancuso, J. J., Setty, M., Sharma, P., Wang, J., Pe’er, D., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.004 · Cited by 97
Halliday, N., Williams, C., Kennedy, A., Waters, E., Pesenacker, A. M., Soskic, B., Hinze, C., Hou, T. Z., Rowshanravan, B., Janman, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.600000 · Cited by 95
BUGEON, L., & DALLMAN, M. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.supplement_3.15tac5 · Cited by 94
Thomas, R. M., Chunder, N., Chen, C., Umetsu, S. E., Winandy, S., & Wells, A. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7305 · Cited by 91
“T cells activated in the absence of CD28 costimulatory signals fail to acetylate and remodel chromatin at the IL2 promoter (5), fail to produce IL-2 (10), and are rendered hyporesponsive to further stimuli (11, 12).”
de Boer, O. J., Hirsch, F., van der Wal, A. C., van der Loos, C. M., Das, P. K., & Becker, A. E. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00135-4 · Cited by 85
Legrand, N., Cupedo, T., van Lent, A. U., Ebeli, M. J., Weijer, K., Hanke, T., & Spits, H. (2006) · Blood · doi:10.1182/blood-2006-01-0190 · Cited by 82
Pawelec, G., Sansom, D., Rehbein, A., Adibzadeh, M., & Beckman, I. (1996) · Experimental Gerontology · doi:10.1016/s0531-5565(96)00097-6 · Cited by 68
Porciello, N., & Tuosto, L. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.02.004 · Cited by 61
Yang, S., Li, W., Liu, W., Gao, C., Zhou, B., Li, S., Li, Y., & Kong, Y. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.009 · Cited by 40
Glutamine supplementation improves the efficacy of miltefosine treatment for visceral leishmaniasis
Ferreira, C., Mesquita, I., Barbosa, A. M., Osório, N. S., Torrado, E., Beauparlant, C.-J., Droit, A., Cunha, C., Carvalho, A., Saha, B., et al. (2020) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0008125 · Cited by 35
Annila, I. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00885.x · Cited by 25
Manzke, O., Titzer, S., Tesch, H., Diehl, V., & Bohlen, H. (1997) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620050432 · Cited by 20
Wilson, L., Lewis, K. E., Evans, L. S., Dillon, S. R., & Pepple, K. L. (2023) · Translational Vision Science & Technology · doi:10.1167/tvst.12.3.27 · Cited by 5
Metadata
- Authors
- Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P.
- Venue
- Nature
- Published
- 1992-04
- Volume
- 356
- Issue
- 6370
- Pages
- 607-609
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2040572245
- Cited by
- 1,559
- References
- 17
- FWCI
- 37.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.